TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
RGEN

Repligen Corporation

Healthcare · Medical Instruments & Supplies

176.90$ -0.7% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement RGEN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
44.1% 42.2% 45.1% 47.5% 44.3% 48.9% 46.9% 41.7% 43.1% 55.5% 56.7% 52.9%
55.9% 57.8% 54.9% 52.5% 55.7% 51.1% 53.1% 58.3% 56.9% 44.5% 43.3% 47.1%
8.8% 6.9% 7.0% 6.1% 8.1% 7.2% 5.4% 5.1% 5.5% 6.7% 6.8% 7.3%
27.0% 29.6% 29.5% 36.5% 33.9% 35.4% 32.7% 27.4% 26.9% 33.5% 41.5% 39.4%
35.8% 36.4% 36.5% 42.6% 42.3% 36.3% 30.9% 33.4% 28.8% 36.0% 48.8% 39.0%
16.8% 16.5% 15.3% 9.9% 13.4% 14.8% 22.2% 24.9% 28.0% 8.5% -5.5% 8.1%
0.1% 0.0% 3.6% 4.6% 3.5% 3.4% 3.3% 1.9% 0.4% 1.6% 3.6% 3.1%
17.5% 16.1% 11.2% 5.1% 11.0% 9.7% 16.2% 22.9% 27.3% 10.0% -4.3% 8.5%
4.7% 4.9% 0.0% -14.9% 2.5% 1.8% -0.2% 3.8% 4.1% 3.5% -0.2% 1.8%
12.9% 11.2% 11.2% 20.1% 8.6% 7.9% 16.4% 19.1% 23.2% 6.5% -4.0% 6.6%
23.9% 26.9% 23.5% 17.1% 21.5% 20.8% 26.9% 30.3% 34.6% 19.5% 12.7% 22.3%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?